Literature DB >> 27330465

Response to phenylephrine testing in upper eyelids with ptosis.

N Grace Lee1, Li-Wei Lin2, Sonia Mehta3, Suzanne K Freitag1.   

Abstract

OBJECTIVE: To evaluate the response of ptotic upper eyelids to topical phenylephrine 10%.
METHODS: The medical records of patients referred for ptosis evaluation over an 18-month period were retrospectively reviewed. Seventy-seven ptotic upper eyelids with aponeurotic dehiscence in 47 patients were given 1 drop of 10% phenylephrine. Margin-to-reflex distance 1 (MRD1) and levator excursion were recorded and photography of lid height was performed both pre- and 5 minutes post-phenylephrine testing.
RESULTS: A total of 77 ptotic upper eyelids of 47 patients were included. In 22% of lids, phenylephrine testing produced no response; in 18%, lid elevation of 0.5-1 mm; in 35%, elevation of 1.5-2 mm; and in 25%, elevation of > 2 mm. Subgroup analyses revealed a higher proportion of response in cases of mild to moderate ptosis compared with cases of severe ptosis. The amount of levator function in these cases of aponeurotic dehiscence did not correlate with the amount of response to phenylephrine.
CONCLUSIONS: A majority of ptotic eyelids, regardless of levator function, responded to topical phenylephrine, which has been demonstrated to be necessary for successful Müller's muscle resection ptosis repair. While the severity of ptosis was linked to eyelid response to phenylephrine, the degree of levator function did not appear to affect an eyelid's response to phenylephrine. In this study cohort, phenylephrine was shown to stimulate Müller's muscle contraction independently of levator function.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 27330465      PMCID: PMC4902646          DOI: 10.5693/djo.01.2015.05.001

Source DB:  PubMed          Journal:  Digit J Ophthalmol        ISSN: 1542-8958


  13 in total

1.  Müller muscle-conjunctiva resection. Technique for treatment of blepharoptosis.

Authors:  A M Putterman; M J Urist
Journal:  Arch Ophthalmol       Date:  1975-08

2.  Levator resection for minimal ptosis: another simplified operation.

Authors:  R M FASANELLA; J SERVAT
Journal:  Arch Ophthalmol       Date:  1961-04

3.  Müller muscle conjunctival resection for blepharoptosis in patients with poor to fair levator function.

Authors:  Dan Georgescu; Gil Epstein; Tamara Fountain; Michael Migliori; Geva Mannor; David Weinberg
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2009 Nov-Dec

4.  Experience with the modified Putterman procedure.

Authors:  B Guyuron; B Davies
Journal:  Plast Reconstr Surg       Date:  1988-11       Impact factor: 4.730

5.  Surgical microanatomy of the müller muscle-conjunctival resection ptosis procedure.

Authors:  Marcus M Marcet; Pete Setabutr; Bradley N Lemke; Megan E Collins; James C Fleming; Ralph E Wesley; Jayant M Pinto; Allen M Putterman
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2010 Sep-Oct       Impact factor: 1.746

6.  Muller's muscle resection for ptosis and relationship with levator and Muller's muscle function.

Authors:  Rajat Maheshwari; Sejal Maheshwari
Journal:  Orbit       Date:  2011-06

7.  Müllers muscle-conjunctival resection ptosis procedure.

Authors:  A M Putterman
Journal:  Aust N Z J Ophthalmol       Date:  1985-05

8.  Müller's muscle-conjunctival resection ptosis procedure.

Authors:  A M Putterman; M J Urist
Journal:  Ophthalmic Surg       Date:  1978-06

9.  Possible adverse effects from topical ocular 10% phenylephrine.

Authors:  F T Fraunfelder; A F Scafidi
Journal:  Am J Ophthalmol       Date:  1978-04       Impact factor: 5.258

10.  Comparison of 2.5% and 10% phenylephrine in the elevation of upper eyelids with ptosis.

Authors:  H J Glatt; D R Fett; A M Putterman
Journal:  Ophthalmic Surg       Date:  1990-03
View more
  6 in total

1.  Clinical value of phenylephrine testing in the upper and lower eyelids of patients with aponeurotic and congenital eyelid ptosis.

Authors:  Ozgun Melike Gedar Totuk; Meltem Guzin Altinel; Ayse Yagmur Kanra; Umit Aykan
Journal:  Int J Ophthalmol       Date:  2022-09-18       Impact factor: 1.645

2.  Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials.

Authors:  David L Wirta; Michael S Korenfeld; Shane Foster; Robert Smyth-Medina; Jason Bacharach; Shane R Kannarr; Mark J Jaros; Charles B Slonim
Journal:  Clin Ophthalmol       Date:  2021-10-08

3.  Effect of Muller's muscle-conjunctival resection on the upper eyelid crease position in Asian eyelids: a retrospective cohort study.

Authors:  Hung-Ju Chen; Chun-Yuan Wang; Yu-Fang Huang; Yu-Chieh Wu; Li-Chen Wei
Journal:  BMC Ophthalmol       Date:  2022-09-21       Impact factor: 2.086

Review 4.  Botulinum toxin-induced blepharoptosis: Anatomy, etiology, prevention, and therapeutic options.

Authors:  Mark S Nestor; Haowei Han; Anita Gade; Daniel Fischer; Yves Saban; Roberto Polselli
Journal:  J Cosmet Dermatol       Date:  2021-08-11       Impact factor: 2.189

5.  Outcomes of Early Correction of Congenital Myogenic Ptosis Using Transconjunctival Levator Plication.

Authors:  Zoran Zikić; Milorad Ljutica; Reuf Karabeg; Miroslav Stamenkovic
Journal:  Med Arch       Date:  2020-06

6.  Time-dependent Response of Eyelid Height with a Single Drop of 2.5% Phenylephrine in Korean Ptotic Patients.

Authors:  Moon Kyeong Shin; Nam Yeong Kim; Hee Bae Ahn
Journal:  Korean J Ophthalmol       Date:  2020-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.